Landmark paper in Nature Communications highlights continued advances in Evox Therapeutics’s proprietary exosome engineering platform

Novel scaffold proteins for improved drug loading published by Evox co-founder Oxford, UK, August 9, 2023 – Evox Therapeutics Ltd (‘Evox’), a leading exosome therapeutics company, today announced the publication in Nature Communications of Evox-funded research identifying novel exosome scaffold proteins that significantly improve drug loading into exosomes for therapeutic purposes. The publication can be … Read more The post Landmark paper in Nature Communications highlights continued advances in Evox Therapeutics’s proprietary exosome engineering platform appeared first on Evox Therapeutics